世界と日本のNSCLC向け標的薬剤BRAF阻害剤の市場規模、現状、予測2021-2027年Global and Japan Targeted Drug BRAF Inhibitors for NSCLC Market Size, Status and Forecast 2021-2027 市場分析と洞察。世界のNSCLC向け標的薬剤BRAF阻害剤市場 世界のNSCLC向け標的薬剤BRAF阻害剤の市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで推移し、2027年にはXX百万米ドルに達すると予... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー市場分析と洞察。世界のNSCLC向け標的薬剤BRAF阻害剤市場世界のNSCLC向け標的薬剤BRAF阻害剤の市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX%のCAGRで推移し、2027年にはXX百万米ドルに達すると予測されています。 本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のNSCLC向け標的薬剤BRAF阻害剤市場で得られる主要な機会を明らかにし、プレイヤーが市場での強力なポジションを獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができます。その中には、収益面での世界的なTargeted Drug BRAF Inhibitors for NSCLC市場の全体的な規模についての予測も含まれています。 本レポートは、世界のNSCLC用ターゲット薬剤BRAF阻害剤市場において、競合他社に対して優位に立ち、永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のNSCLC向け標的薬剤BRAF阻害剤市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。 世界のNSCLC用ターゲット薬BRAF阻害剤の範囲と市場規模 NSCLC用ターゲットドラッグBRAF阻害剤市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界のNSCLC向け標的薬剤BRAF阻害剤市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント Dabrafenib(ダブラフェニブ Trametinib(トラメチニブ Lifirafenib その他 用途別セグメント NSCLCの扁平上皮癌(Squamous Cell Carcinoma of NSCLC NSCLCの腺癌 大細胞癌(NSCLC 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 BeiGene ノバルティス 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Dabrafenib 1.2.3 Trametinib 1.2.4 Lifirafenib 1.2.5 Other 1.3 Market by Application 1.3.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Squamous Cell Carcinoma of NSCLC 1.3.3 Adenocarcinoma of NSCLC 1.3.4 Large Cell Carcinoma of NSCLC 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Perspective (2016-2027) 2.2 Targeted Drug BRAF Inhibitors for NSCLC Growth Trends by Regions 2.2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Targeted Drug BRAF Inhibitors for NSCLC Historic Market Share by Regions (2016-2021) 2.2.3 Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Regions (2022-2027) 2.3 Targeted Drug BRAF Inhibitors for NSCLC Industry Dynamic 2.3.1 Targeted Drug BRAF Inhibitors for NSCLC Market Trends 2.3.2 Targeted Drug BRAF Inhibitors for NSCLC Market Drivers 2.3.3 Targeted Drug BRAF Inhibitors for NSCLC Market Challenges 2.3.4 Targeted Drug BRAF Inhibitors for NSCLC Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue 3.1.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue (2016-2021) 3.1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) 3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue 3.4 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio 3.4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2020 3.5 Targeted Drug BRAF Inhibitors for NSCLC Key Players Head office and Area Served 3.6 Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service 3.7 Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Targeted Drug BRAF Inhibitors for NSCLC Breakdown Data by Type 4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 4.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 5 Targeted Drug BRAF Inhibitors for NSCLC Breakdown Data by Application 5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 5.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 6.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 6.2.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 6.2.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 6.2.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 6.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 6.3.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 6.3.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 6.3.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 6.4 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 6.4.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 6.4.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 7.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 7.2.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 7.2.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 7.2.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 7.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 7.3.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 7.3.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 7.3.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 7.4 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 7.4.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 7.4.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 8.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 8.2.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 8.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 8.3.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 8.4 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region 8.4.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 9.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 9.2.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 9.2.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 9.2.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 9.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 9.3.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 9.3.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 9.3.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 9.4 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 9.4.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 9.4.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 10.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 10.2.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 10.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 10.3.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 10.4 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 10.4.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BeiGene 11.1.1 BeiGene Company Details 11.1.2 BeiGene Business Overview 11.1.3 BeiGene Targeted Drug BRAF Inhibitors for NSCLC Introduction 11.1.4 BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2016-2021) 11.1.5 BeiGene Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Targeted Drug BRAF Inhibitors for NSCLC Introduction 11.2.4 Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2016-2021) 11.2.5 Novartis Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryMarket Analysis and Insights: Global Targeted Drug BRAF Inhibitors for NSCLC Market Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Dabrafenib 1.2.3 Trametinib 1.2.4 Lifirafenib 1.2.5 Other 1.3 Market by Application 1.3.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Squamous Cell Carcinoma of NSCLC 1.3.3 Adenocarcinoma of NSCLC 1.3.4 Large Cell Carcinoma of NSCLC 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Perspective (2016-2027) 2.2 Targeted Drug BRAF Inhibitors for NSCLC Growth Trends by Regions 2.2.1 Targeted Drug BRAF Inhibitors for NSCLC Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Targeted Drug BRAF Inhibitors for NSCLC Historic Market Share by Regions (2016-2021) 2.2.3 Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Regions (2022-2027) 2.3 Targeted Drug BRAF Inhibitors for NSCLC Industry Dynamic 2.3.1 Targeted Drug BRAF Inhibitors for NSCLC Market Trends 2.3.2 Targeted Drug BRAF Inhibitors for NSCLC Market Drivers 2.3.3 Targeted Drug BRAF Inhibitors for NSCLC Market Challenges 2.3.4 Targeted Drug BRAF Inhibitors for NSCLC Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue 3.1.1 Global Top Targeted Drug BRAF Inhibitors for NSCLC Players by Revenue (2016-2021) 3.1.2 Global Targeted Drug BRAF Inhibitors for NSCLC Revenue Market Share by Players (2016-2021) 3.2 Global Targeted Drug BRAF Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Targeted Drug BRAF Inhibitors for NSCLC Revenue 3.4 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio 3.4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug BRAF Inhibitors for NSCLC Revenue in 2020 3.5 Targeted Drug BRAF Inhibitors for NSCLC Key Players Head office and Area Served 3.6 Key Players Targeted Drug BRAF Inhibitors for NSCLC Product Solution and Service 3.7 Date of Enter into Targeted Drug BRAF Inhibitors for NSCLC Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Targeted Drug BRAF Inhibitors for NSCLC Breakdown Data by Type 4.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Type (2016-2021) 4.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Type (2022-2027) 5 Targeted Drug BRAF Inhibitors for NSCLC Breakdown Data by Application 5.1 Global Targeted Drug BRAF Inhibitors for NSCLC Historic Market Size by Application (2016-2021) 5.2 Global Targeted Drug BRAF Inhibitors for NSCLC Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 6.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 6.2.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 6.2.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 6.2.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 6.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 6.3.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 6.3.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 6.3.3 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 6.4 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 6.4.1 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 6.4.2 North America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 7.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 7.2.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 7.2.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 7.2.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 7.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 7.3.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 7.3.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 7.3.3 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 7.4 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 7.4.1 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 7.4.2 Europe Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 8.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 8.2.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 8.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 8.3.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 8.4 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region 8.4.1 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Targeted Drug BRAF Inhibitors for NSCLC Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 9.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 9.2.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 9.2.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 9.2.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 9.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 9.3.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 9.3.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 9.3.3 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 9.4 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 9.4.1 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 9.4.2 Latin America Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size (2016-2027) 10.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type 10.2.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Type (2016-2027) 10.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application 10.3.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Application (2016-2027) 10.4 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country 10.4.1 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Targeted Drug BRAF Inhibitors for NSCLC Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BeiGene 11.1.1 BeiGene Company Details 11.1.2 BeiGene Business Overview 11.1.3 BeiGene Targeted Drug BRAF Inhibitors for NSCLC Introduction 11.1.4 BeiGene Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2016-2021) 11.1.5 BeiGene Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Targeted Drug BRAF Inhibitors for NSCLC Introduction 11.2.4 Novartis Revenue in Targeted Drug BRAF Inhibitors for NSCLC Business (2016-2021) 11.2.5 Novartis Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗感染性薬物)の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |